HealthTech

eGenesis

eGenesis raises $191M Series D

$191M
Total Raised
Series D
Latest Round
2015
Founded
200+
Employees
Cambridge, MA
1 min read

Quick Facts

Latest Round Size
$191M
Latest Round Date
August 2025

eGenesis: Series D Funding Round

eGenesis has successfully raised $191M in Series D funding.

Company Overview

Biotech company developing human-compatible engineered organs through xenotransplantation

Funding Details

The Series D round was led by Lux Capital.

Company Information

  • Headquarters: Cambridge, MA
  • Founded: 2015
  • Employees: 200+
  • Category: HealthTech

Investment

eGenesis plans to use the funds to accelerate product development, expand its team, and scale operations globally.

About the Investors

  • Lux Capital: Verified investor in Series D

Key Investors

Lux Capital
Lead Investor
Verified investor in Series D

About the Author

Editorial Team
Editorial Team
Curated funding news from verified sources